On an international level, Dr. Hakan Kaymak is one of the leading minds of his field of expertise. He is one of the first in the whole world and the first overall in Düsseldorf to regularly use the minimally invasive 23-gauge technique in vitreous body and retina operations. Over time, the instruments have become even smaller, and he is now among the first users of the 27-gauge technique in which the instruments have an external diameter of 0.4mm.
Furthermore, Dr. Kaymak contributed to developing some modern intraocular lens systems. In 2007, he was awarded a Sci-Tech Award for his work in the field of aberration-correcting lenses by the American ophthalmologic surgeons.
He is a member of the programming commission of the congress of Deutsche OphthalmoChirurgen [German association of ophthalmologic surgeons] and the review panel of the Journal of Cataract and Refractive Surgery; he is working closely with Prof. Dr. Frank Schaeffel (Tübingen). Only in September 2014, he published a joint paper on a new measuring technique for intraocular lenses with Prof. Schaeffel.
Main fields of activity:
Surgical and non-surgical therapy of diseases of the vitreous body, retina and macula:
- E.g. age-related macular degeneration (AMD)
- Central serous chorioretinopathy (CSC)
- Vitreomacular traction syndrome (VMTS)
- Clouding of the vitreous body (floaters)
- Diabetes-related eye diseases
Range of therapies:
- Retinal laser regeneration therapy (2RT)
- Floater laser therapy
- IVOM therapy (injection of medications)
- Minimally invasive operations of the vitreous body (25- and 27-gauge)
- Implantation of premium lenses / AMD lenses (for macular degeneration)